ABSTRACT
Maternal dietary patterns during pregnancy have been demonstrated to impact the structure of the gut microbiota in offspring, altering their susceptibility to diseases. This study is designed to elucidate whether the impact of folic acid supplementation during pregnancy on hepatic steatosis in male offspring of rat dams exposed to a high-fat diet (HFD) is related to gut-liver axis homeostasis. In this study, female rats were administered a HFD and simultaneously supplemented with 5 mg/kg folic acid throughout their pregnancy. Histopathological examination showed that folic acid supplementation effectively ameliorated hepatic lipid accumulation and inflammatory infiltrate in male offspring subjected to a maternal HFD. Maternal folic acid supplementation reduced the abundance of Desulfobacterota and the Firmicutes/Bacteroidota (F/B) ratio in male offspring. The expression of tight junction proteins in the colon was significantly upregulated, and the serum LPS level was significantly reduced. Furthermore, there was a notable reduction in the hepatic expression of the TLR4/NF-κB signaling pathway and subsequent inflammatory mediators. Spearman's correlation analysis revealed significant associations between hepatic inflammation-related indices and several gut microbiota, particularly Desulfobacterota and Lactobacillus. With a reduction in hepatic inflammation, the expression of PPAR-α was upregulated, and the expression of SREBP-1c and its downstream lipid metabolism-related genes was downregulated. In summary, folic acid supplementation during pregnancy modulates gut microbiota and enhances intestinal barrier integrity in male offspring of HFD dams. This helps reduce the LPS leakage and suppress the expression of TLR4/NF-κB pathway in the liver, thereby improving lipid metabolism disorders, and alleviating hepatic steatosis.
Subject(s)
Fatty Liver , Gastrointestinal Microbiome , Pregnancy , Rats , Animals , Male , Female , Mice , Diet, High-Fat/adverse effects , Lipopolysaccharides/pharmacology , NF-kappa B/metabolism , Toll-Like Receptor 4/metabolism , Fatty Liver/prevention & control , Fatty Liver/metabolism , Liver/metabolism , Dietary Supplements , Folic Acid/pharmacology , Folic Acid/metabolism , Inflammation/metabolism , Mice, Inbred C57BLABSTRACT
The purpose of this study was to investigate the effect of aqueous extract of Corni Fructus on ß-amyloid protein 25-35(Aß_(25-35))-induced brain injury and neuroinflammation in Alzheimer's disease(AD) mice to provide an experimental basis for the treatment of AD by aqueous extract of Corni Fructus. Sixty C57BL/6J male mice were randomly divided into a sham group, a model group, a positive control group(huperizine A, 0.2 mg·kg~(-1)), a low-dose aqueous extract of Corni Fructus group(1.3 g·kg~(-1)), a medium-dose aqueous extract of Corni Fructus group(2.6 g·kg~(-1)), and a high-dose aqueous extract of Corni Fructus group(5.2 g·kg~(-1)). The AD model was induced by lateral ventricular injection of Aß_(25-35) in mice except for those in the sham group, and AD model mice were treated with corresponding drugs by gavage for 24 days. The behavioral test was performed one week before animal dissection. Hematoxylin-eosin(HE) staining was performed to observe the morphology of neurons in the hippocampal region. Flow cytometry was used to detect the apoptosis level of primary hippocampal cells in mice. ELISA kits were used to detect the levels of ß-amyloid protein 1-42(Aß_(1-42)) and phosphorylated microtubule-associated protein Tau(p-Tau) in mouse brain tissues. Immunofluorescence and Western blot were used to detect the expression of related proteins in mouse brain tissues. MTT assay was used to detect the effect of compounds in aqueous extract of Corni Fructus on Aß_(25-35)-induced N9 cell injury. Molecular docking was employed to analyze the interactions of caffeic acid, trans-p-hydroxy cinnamic acid, isolariciresinol-9'-O-ß-D-glucopyranoside, esculetin, and(+)-lyoniresinol with ß-amyloid precursor protein(APP), interleukin-6(IL-6), and tumor necrosis factor-α(TNF-α). Aqueous extract of Corni Fructus could improve the learning and memory abilities of Aß_(25-35)-induced mice by increasing the duration of the autonomous activity, the rate of autonomous alternation, the preference coefficient, and the discrimination coefficient, and reduce Aß_(25-35)-induced brain injury and neuroinflammation in mice by increasing the expression levels of interleukin-10(IL-10) and B-cell lymphoma-2(Bcl-2) in brain tissues, decreasing the expression levels of Aß_(1-42), p-Tau, IL-6, TNF-α, cysteine aspartate-specific protease 3(caspase-3), cysteine aspartate-specific protease 9(caspase-9), and Bcl-2-associated X protein(Bax), and decreasing the number of activated glial cells in brain tissues. The results of cell experiments showed that esculetin and(+)-lyoniresinol could improve Aß_(25-35)-induced N9 cell injury. Molecular docking results showed that caffeic acid, trans-p-hydroxy cinnamic acid, isolariciresinol-9'-O-ß-D-glucopyranoside, esculetin, and(+)-lyoniresinol had good binding affinity with APP and weak binding affinity with IL-6 and TNF-α. Aqueous extract of Corni Fructus could ameliorate cognitive dysfunction and brain damage in Aß_(25-35)-induced mice by reducing the number of apoptotic cells and activated glial cells in the brain and decreasing the expression level of inflammatory factors. Caffeic acid, trans-p-hydroxy cinnamic acid, isolariciresinol-9'-O-ß-D-glucopyranoside, esculetin, and(+)-lyoniresinol may be the material basis for the anti-AD effect of aqueous extract of Corni Fructus.
Subject(s)
Alzheimer Disease , Brain Injuries , Cornus , Mice , Male , Animals , Alzheimer Disease/chemically induced , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/toxicity , Amyloid beta-Peptides/metabolism , Cornus/metabolism , Neuroinflammatory Diseases , Tumor Necrosis Factor-alpha/metabolism , Interleukin-6 , Aspartic Acid , Cysteine/therapeutic use , Molecular Docking Simulation , Mice, Inbred C57BL , Peptide Hydrolases , Disease Models, Animal , Mice, TransgenicABSTRACT
BACKGROUND: Up to 90% of patients who are under the active treatment suffer from cancer-related fatigue (CRF). CRF can persist about 10 years after diagnosis and/or treatment. Accumulating reports support that ginseng and ginseng injections are both potential drugs for the treatment of CRF but few studies put them together for analysis. METHODS: Two reviewers independently extracted data in 3 databases (PubMed, Cochrane Library and China National Knowledge Infrastructure) from their inception to May 24, 2021. The primary outcome was the effect of ginseng in alleviating CRF. The secondary outcome was ginseng in alleviating emotional or cognitive fatigue. Standardized mean difference (SMD) was employed. RESULTS: Twelve studies were included to evaluate efficacy of ginseng oral administration and ginseng injections on CRF. The pooled SMD was 0.40 (95% confidence Interval [95% CI] [0.29-0.51], Pâ <â .00001). Six studies were included to evaluate efficacy of ginseng oral administration on CRF and the SMD was 0.29 (95% CI [0.15-0.42], Pâ <â .0001). The order was 2000 mg/d, 3000 mg/d, 1000 mg/d and placebo from high efficacy to low. Ten studies were included to evaluate efficacy of ginseng injections on CRF and the SMD was 0.74 (95% CI [0.59-0.90], Pâ <â .00001). Emotional fatigue was reported in 4 studies, ginseng oral administration in 2 and ginseng injections in 2. The pooled SMD was 0.12 (95% CI [-0.04 to 0.29], Pâ =â .15). Cognitive fatigue was reported in 4 studies focusing on ginseng injections and the SMD was 0.72 (95% CI [0.48-0.96], Pâ <â .00001). CONCLUSION: Ginseng can improve CRF. Intravenous injection might be better than oral administration. Ginseng injections may alleviate cognitive fatigue. No evidence was found to support that ginseng could alleviate emotional fatigue.
Subject(s)
Neoplasms , Panax , Humans , Fatigue/etiology , Fatigue/complications , Neoplasms/complications , Neoplasms/therapy , Injections , Administration, OralABSTRACT
OBJECTIVE: To investigate the efficacy of Sijunzi decoction () on limb weakness in a rat model of spleen Qi deficiency (SQD), and to study its effect on mitophagy in skeletal muscle through adenosine monophosphate-activated protein kinase (AMPK) / unc-51 like autophagy activating kinase 1 (ULK1) signaling. METHODS: SQD model rats were produced by fasting combined with forced swimming method for 15 d. After model assessment, rats were randomly divided into four groups of 10 [low/middle/high (L/M/H) Sijunzi decoction dose groups and a normal saline (S) group]. Limb holding power (HP) and body mass (BM) were measured after 2 weeks of treatment. Following euthanasia, quadriceps femoris were dissected and myofiber and mitochondrial morphology were observed by transmission electron microscopy (TEM). Mitochondrial membrane potential (MMP), adenosine triphosphatase (ATP) and reactive oxygen species (ROS) levels were determined using colorimetric methods, and immunoblot analysis of Microtubule-associated protein light chain 3 (LC3) and Sequestosome 1 (p62) was performed to monitor mitophagy and AMPK/ULK1 signaling. RESULTS: Compared with control (C) group rats, in the S group, HP was reduced, the myofiber Z line was disordered, mitochondria were scattered, and numerous vacuoles and mitophagy were observed. MMP and ATP levels were reduced, ROS levels were elevated, and LC3B expression, and p-AMPKα (Thr172)/AMPKα, p-ULK1 (Ser555)/ULK1, and p-Raptor (Ser792)/Raptor ratios were increased, while p62 expression and p-mTOR (Ser2448)/mTOR and p-ULK1 (Ser757)/ULK1 ratios were decreased. After treatment, compared with the S group, HP was improved in M and H groups but not in the L group. Mitophagy was reduced in M, H and L groups but the Z line was disordered and vacuolization remained in the L group. ATP levels were elevated in M, H and L groups, and MMPs were elevat-ed in M and H groups but not in the L group. ROS levels were decreased in M, H and L groups, as were LC3B expression and p-Raptor (Ser792)/Raptor ratios, while p62 expression and p-mTOR (Ser2448)/mTOR and p-ULK1 (Ser757)/ULK1 ratios were increased in M and H groups but not in the L group. p-AMPKα (Thr172)/AMPKα and p-ULK1 (Ser555)/ULK1 ratios were decreased in M, H and L groups. CONCLUSIONS: Sijunzi decoction improved HP, possibly by inhibiting mitophagy via suppression of AMPK/ULK1 signaling. This restored mitochondrial morphology and improved oxidative phosphorylation, which contributed to recovery of limb weakness in SQD model rats.
Subject(s)
Qi , Spleen , Adenosine Monophosphate , Animals , Autophagy-Related Protein-1 Homolog/genetics , Drugs, Chinese Herbal , Protein Kinases , RatsABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Inonotus obliquus (Fr.) Pilat is a mushroom belonging to the family Hymenochaetaceae. It is popularly called the Chaga mushroom in Russian folk medicine and has been used as a traditional medicine to treat diabetes mellitus in Eastern European and Asian countries. However, its effects on glycolipid metabolism disorders and underlying molecular mechanism of action remain unclear. AIM OF THE STUDY: I. obliquus contains abundant functional components, which provide potential medicinal value. The purpose of this study was to investigate compositions of I. obliquus extract with a high-pressure water extraction method, and investigate the anti-type 2 diabetic effects of I. obliquus extract and the possible underlying mechanisms involved. MATERIALS AND METHODS: The I. obliquus was extracted by a high-pressure water extraction method, and tested its main components by special assay kit and instrumental analysis. Type 2 diabetic C57BL/6 mice were induced by high-fat diet with low-dose STZ injection, and were daily gavaged with different doses of I. obliquus extract for 8 weeks. Glycemic, blood lipid profile, and histopathology of liver and pancreas were assessed. Underlying mechanisms related to glycemic control in liver were further performed. RESULTS: The I. obliquus extract main compounds were ß-Glucans, triterpenoids and polyphenol by determination. Oral administration of 250 mg/kg and 500 mg/kg I. obliquus extract significantly alleviated blood glucose and insulin resistance. Moreover, 250 mg/kg and 500 mg/kg of I. obliquus extract increased liver glycogen content and high-density lipoprotein cholesterol (HDL-C) levels while decreased total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) levels. Furthermore, the protein expression levels of phosphatidylinositol-3 kinase (PI3K), p-protein kinase B (Akt), p-adenosine monophosphate activated protein kinase (AMPK), and p-acetyl-CoA carboxylase (ACC) were upregulated, whereas sterol regulatory element-binding protein-1c (SREBP-1c) and fatty acid synthase (FAS) were downregulated after supplement with 250 mg/kg and 500 mg/kg of I. obliquus extract. Interestingly, I. obliquus extract was a dose-effect relationship within a certain range. 250 mg/kg had obvious anti-diabetes effect, and the effect of 500 mg/kg dose was the same as that of metformin. CONCLUSION: I. obliquus extract ameliorated insulin resistance and lipid metabolism disorders in diabetic mice. The hypoglycemic and hypolipidemic properties of I. obliquus extract were supposedly exerted via the regulation of the PI3K/Akt and AMPK/ACC signaling pathways.
Subject(s)
Glycolipids/metabolism , Inonotus/chemistry , Lipid Metabolism/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Acetyl-CoA Carboxylase/genetics , Acetyl-CoA Carboxylase/metabolism , Adenylate Kinase/genetics , Adenylate Kinase/metabolism , Animals , Biological Products/chemistry , Biological Products/pharmacology , Blood Glucose , Diabetes Mellitus, Experimental/drug therapy , Diet, High-Fat/adverse effects , Gene Expression Regulation/drug effects , Hypolipidemic Agents , Male , Mice , Phosphatidylinositol 3-Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Random AllocationABSTRACT
Probiotics and plant extracts are considered to prevent the development of non-alcoholic fatty liver disease (NAFLD). The present study explores the effects of using both probiotics and plant extracts on NAFLD. The present study evaluated the effects of plant extracts on lipid droplet accumulation and the growth of probiotics in vitro. A C57BL/6 mouse model was used to examine the effects of probiotics and plant extracts on NAFLD. Body weight and food intake were measured. The levels of serum lipids, oxidative stress and the liver injury index were determined using commercial kits. Haematoxylin and eosin staining, GC and real-time PCR were also used for analysis. The results revealed that administration of Lactobacillus casei YRL577 and L. paracasei X11 with resveratrol (RES) or tea polyphenols (TP) significantly reduced the levels of total cholesterol, TAG and LDL-cholesterol and increased the level of the HDL-cholesterol. The groups of L. casei YRL577 with RES and TP also regulated the liver structure, oxidative stress and injury. Furthermore, L. casei YRL577 with TP exhibited a more positive effect towards improving the NAFLD and increased the concentrations of the butyric acid than other three combined groups. L. casei YRL577 with TP up-regulated the mRNA levels of the farnesoid X receptor and fibroblast growth factor 15 and decreased the mRNA levels of the apical Na-dependent bile acid transporter. These findings showed that L. casei YRL577 + TP-modified genes in the intestinal bile acid pathway improved markers of NAFLD.
Subject(s)
Isoflavones/therapeutic use , Lacticaseibacillus casei , Non-alcoholic Fatty Liver Disease/therapy , Polyphenols/therapeutic use , Probiotics/therapeutic use , Resveratrol/therapeutic use , Animals , Bile Acids and Salts/metabolism , Body Weight , Camellia sinensis/chemistry , Diet, High-Fat/adverse effects , Gene Expression Regulation/drug effects , Hep G2 Cells , Humans , Isoflavones/chemistry , Lipid Metabolism/drug effects , Liver/drug effects , Male , Mice , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease/chemically induced , Organ Size/drug effects , Polyphenols/administration & dosage , Polyphenols/chemistry , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Resveratrol/chemistry , Glycine max/chemistryABSTRACT
BACKGROUND: Electroacupuncture is well known for its advantageous neuroanalgesic and therapeutic effects on myocardial ischemia-reperfusion injury. The purpose of the present research was to verify whether electroacupuncture can alleviate bupivacaine-induced myocardial injury. METHODS: Specific pathogen-free Wistar rats were used to establish the bupivacaine-induced myocardial injury model. Western blot, PCR, transmission electron microscope and enzyme-linked immunosorbent (ELISA) methods were used to evaluate bupivacaine-induced structure injury and dysfunction of the mitochondria as well as the alleviating effects of lipid emulsion, acupoint injection, and electroacupuncture pre-treatment of the oxidase stress response. RESULTS: Bupivacaine caused structural damage, degradation, and swelling of mitochondria. Furthermore, it reduced adenosine triphosphate (ATP) synthesis and impaired energy metabolism in the mitochondria. Structural and functional impairment of the mitochondria was alleviated via lipid emulsion injection, acupoint injection, and electroacupuncture pre-treatment. Electroacupuncture pre-treatment of PC6 yielded a greater alleviating effect than others approaches. Following electroacupuncture pre-treatment of PC6 point, the number of mitochondria increased; apoptosis was reduced, enzymatic activity of cytochrome C oxidase (COX) and superoxide dismutase and expression of uncoupling protein 2, voltage-dependent anion channel 1, and Bcl 2 were upregulated and SLC25A6, MDA levels were downregulated. Additionally, our findings indicated that electroacupuncture pre-treatment of PC6 point exerted an effect on the mitochondria via the mitochondrial-transcription-factor-A/nuclear-respiratory-factor-1/proliferator-activated-receptor-gamma-coactivator-1 pathway. CONCLUSION: The present study revealed that electroacupuncture pre-treatment of PC6 could effectively alleviate bupivacaine-induced myocardial mitochondrial damage, thereby providing a theoretical basis for clinical studies and applications of this treatment method.
Subject(s)
Bupivacaine/toxicity , Electroacupuncture/methods , Mitochondria, Heart/physiology , Mitochondrial Proteins/metabolism , Myocardial Reperfusion Injury/prevention & control , Anesthetics, Local/toxicity , Animals , Apoptosis , Male , Mitochondrial Proteins/genetics , Myocardial Reperfusion Injury/chemically induced , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/pathology , Oxidative Stress , Rats , Rats, WistarABSTRACT
The aim of this study was to evaluate the effect of feeding decoction of a traditional nourishing Chinese herbal medicine formula on rates of plasma phenylalanine and tyrosine turnover and whole body protein synthesis in sheep. Ruminal fermentation characteristics and blood metabolites were also determined. Six sheep were subjected to either mixed hay (MH-diet, as control) or MH-diet supplemented with 2% of Chinese herbal medicine (mixture of Astragalus root, Angelica root, and Atractylodes rhizome; CHM-diet) in a crossover design for each of 3-week period. The isotope dilution of [2 H5 ]phenylalanine and [2 H2 ]tyrosine was performed as a primed-continuous infusion to measure plasma phenylalanine and tyrosine kinetics. Concentrations of total volatile fatty acid, acetate, and propionate in the rumen tended to be higher (p < 0.10), and the pH value was lower (p = 0.04) for the CHM-diet than the MH-diet. Turnover rates of plasma phenylalanine and tyrosine tended to be higher (p < 0.10) for the CHM-diet than the MH-diet. Furthermore, whole body protein synthesis was greater (p = 0.04) for the CHM-diet compared with the MH-diet. The Chinese herbal medicine improved rumen fermentation and enhanced protein metabolism in sheep. Hence, it is suggested that the decoction of Chinese herbal medicine formula could be considered as a potential feed additive for ruminant production.
Subject(s)
Diet/veterinary , Drugs, Chinese Herbal/pharmacology , Phenylalanine/blood , Protein Biosynthesis/drug effects , Sheep/blood , Sheep/metabolism , Tyrosine/blood , Angelica , Animals , Astragalus Plant , Atractylodes , Cross-Over Studies , Fermentation/drug effects , Male , Rumen/metabolismABSTRACT
BACKGROUND & AIMS: The Potential benefits and possible risks of perioperative supplementation with probiotics/synbiotics in surgical patients are not fully understood. Recent evidence has rapidly evolved and conveys conflicting results. Thus, we undertook a meta-analysis of randomized controlled trials (RCTs) to valuate the effectiveness, safety, cost-effectiveness and quality of life of perioperative supplementation with pro-/synbiotics. METHODS: We systematically searched PubMed, Embase and the Cochrane Library through October 2015 to identify RCTs that assessed the effects of perioperative supplementation with pro-/synbiotics in surgical patients. The predefined primary efficacy outcome was surgical site infection (SSI). Random-effects model was applied to pool outcome data accounting for clinical heterogeneity. RESULTS: Our meta-analysis included data from 34 trials comprising 2634 participants, of whom 1300 received perioperative pro-/synbiotics intervention and 1334 received valid control treatment. Compared with the control group, patients in the pro-/synbiotics group had a lower risk of SSI (relative risk: 0.65; 95% confidence interval: 0.51, 0.84; P = 0.0007). Trial sequential analysis confirmed the evidence was sufficient and conclusive. Subgroup analyses indicated the findings were consistent in all subgroup analyses except for the probiotics, enteral feeding, pre-/postoperative and live transplantation subgroups. Pro-/synbiotics also reduced the incidence of other infectious complications (including any infection, pneumonia, urinary tract infection, wound infection and sepsis); shortened antibiotic therapy, intensive care unit stay and hospital stay; and promoted earlier first defecation and first bowel movement. Pro-/synbiotics further reduced the incidence of abdominal side effects, lowered hospital costs and improved the Gastro-Intestinal Quality of Life. CONCLUSIONS: For surgical patients, perioperative supplementation with pro-/synbiotics is effective in preventing or controlling SSI and other infectious complications. Perioperative pro-/synbiotics might also be associated with fewer side effects, lower hospital cost and better quality of life. Current evidence indicated that perioperative synbiotics supplementation is preferred and recommended as an adjunct in surgical patients.
Subject(s)
Dietary Supplements , Infection Control/methods , Length of Stay/statistics & numerical data , Probiotics/therapeutic use , Surgical Procedures, Operative , Synbiotics/administration & dosage , Cost-Benefit Analysis/economics , Cost-Benefit Analysis/statistics & numerical data , Humans , Perioperative Care/methods , Probiotics/economics , Quality of Life , Randomized Controlled Trials as Topic , Synbiotics/economics , Treatment OutcomeABSTRACT
OBJECTIVE: To observe the effect of acupuncture along affected meridian on the mem- brane metallo-endopeptidase (MME) gene expression of migraine patients without aura (MO) of Gan-yang hyperactivity syndrome (GYHS). METHODS: Totally 20 MO patients of GYHS were randomly assigned to the acupoint group (acupuncture along affected meridian) and the non-acupoint group, 10 cases in each group. Needling was performed once per day for 10 consecutive days. Gene chip technology was used to obtain two sets of gene expression profiles and analyzed using Gene Ontology (GO). RESULTS: In the acupoint group, MME gene expression decreased after needling (P = 0.0023).That gene was rich in the beta-amyloid metabolic process (P = 3.16E-05) and the peptide metabolic process (P = 0.009612). Its expression was not seen in the non-acupoint group. CONCLUSION: The effect of point selection along affected meridian could be achieved possibly by regulating the MME gene expression.
Subject(s)
Acupuncture Therapy , Endrin/analogs & derivatives , Migraine Disorders/therapy , Acupuncture , Acupuncture Points , Endrin/metabolism , Humans , Meridians , SyndromeABSTRACT
Rubi Fructus, a traditional Chinese medicine, was considered as an anti-inflammatory agent in folk medicine. In the present study, we investigated the signalling pathways involved in the anti-inflammatory effects of goshonoside-F5 (GF5), isolated from Rubi Fructus, in peritoneal macrophages and examined its therapeutic effect in a mouse endotoxic shock model. GF5 decreased NO and PGE2 production in LPS-stimulated macrophages (IC50=3.84 and 3.16µM). This effect involved the suppression of NOS-2 and COX-2 gene expression at the transcriptional level. Examination of the effects of GF5 on NF-κB signalling demonstrated that it inhibits the phosphorylation of IκB-α and IκB-ß, blocking their degradation and the nuclear translocation of the NF-κB p65 subunit. Moreover, inhibition of MAPK signalling was also observed, and phosphorylation of p38 and JNK was suppressed in the presence of GF5. Inflammatory cytokines, including IL-6 and TNF-α, were down-regulated by this compound after activation with LPS (IC50=17.04 and 4.09µM). Additionally, GF5 (30 and 90mg/kg, i.p.) significantly reduced the circulating cytokine levels (IL-6 and TNF-α) and increased survival in a mouse model of endotoxemia. These results show that GF5 significantly inhibits the pro-inflammatory response induced by LPS, both in vitro and in vivo. Our results provide a strong pharmacological basis for further understanding the potential therapeutic role of GF5 in inflammatory disease and shed new light on the bioactivity of ent-labdane diterpene glucoside.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Flavonoids/administration & dosage , Macrophages, Peritoneal/drug effects , Medicine, Chinese Traditional/methods , Shock, Septic/drug therapy , Animals , Cells, Cultured , Immunosuppression Therapy , Inflammation Mediators/metabolism , Interleukin-6/metabolism , Macrophages, Peritoneal/immunology , Mice , Mice, Inbred C57BL , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Nitric Oxide/metabolism , Phosphorylation/drug effects , Rubus/immunology , Shock, Septic/immunology , Shock, Septic/metabolism , Signal Transduction/drug effects , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The objective of the present study was to assess the feeding effects of garlic leaf on microbial N supply (MNS), turnover rates of plasma phenylalanine (PheTR) and tyrosine (TyrTR) and whole body protein synthesis (WBPS) in sheep. The sheep were fed either mixed hay (Hay-diet, as control) or hay plus garlic leaf diet (GL-diet, at a ratio of 9:1) in a crossover design each for a 21 day period. The isotope dilution method using [(2) H5 ]Phe and [(2) H2 ]Tyr was performed on the 21st day of each dietary treatment. Nitrogen intake remained similar between the diets and N absorption and N digestibility were higher (P<0.05) in the GL-diet than Hay-diet. Total purine derivatives excretion and MNS were greater (P<0.05) in the GL-diet than the Hay-diet. Plasma PheTR tended to be higher (P=0.06) during GL feeding and TyrTR did not differ between the diets. Further, WBPS tended to be greater (P=0.05) for the GL-diet compared with the Hay-diet. Hence, the present results suggest that garlic leaf may have positive effects on N metabolism by influencing MNS in sheep and could be used as a potential ruminant feed in the future.
Subject(s)
Bacteria/metabolism , Garlic , Nitrogen/metabolism , Phenylalanine/blood , Protein Biosynthesis/physiology , Sheep/metabolism , Tyrosine/blood , Animal Feed , Animals , Cross-Over Studies , Kinetics , Male , Plant Leaves , Sheep/microbiologyABSTRACT
BACKGROUND: The use of antibiotics in animal diets is facing negative feedback due to the hidden danger of drug residues to human health. Traditional Chinese herbal medicine has been used to replace antibiotics in the past two decades and played an increasingly important role in livestock production. The present study was carried out to assess the feeding effects of a traditional nourishing Chinese herbal medicine mixture on kinetics of plasma glucose, protein and energy metabolism in sheep. Ruminal fermentation characteristics were also determined. METHODS: Four sheep were fed on either mixed hay (MH-diet) or MH-diet supplemented with 2% of Chinese herbal medicine (mixture of Astragalus root, Angelica root and Atractylodes rhizome; CHM-diet) over two 35-day periods using a crossover design. The turnover rate of plasma glucose was measured with an isotope dilution method using [U-13C]glucose. The rates of plasma leucine turnover and leucine oxidation, whole body protein synthesis (WBPS) and metabolic heat production were measured using the [1-13C]leucine dilution and open circuit calorimetry. RESULTS: Body weight gain of sheep was higher (P = 0.03) for CHM-diet than for MH-diet. Rumen pH was lower (P = 0.02), concentration of rumen total volatile fatty acid tended to be higher (P = 0.05) and acetate was higher (P = 0.04) for CHM-diet than for MH-diet. Turnover rates of plasma glucose and leucine did not differ between diets. Oxidation rate of leucine tended to be higher (P = 0.06) for CHM-diet than for MH-diet, but the WBPS did not differ between diets. Metabolic heat production tended to be greater (P = 0.05) for CHM-diet than for MH-diet. CONCLUSIONS: The sheep fed on CHM-diet had a higher body weight gain and showed positive impacts on rumen fermentation and energy metabolism without resulting in any adverse response. Therefore, these results suggested that the Chinese herbal medicine mixture should be considered as a potential feed additive for sheep.
ABSTRACT
Two new tetrahydrofuran lignans, schiglaucin A and B (1-2), together with eight known analogues (3-10), were isolated from the stems of Schisandra glaucescens Diels. Their structures were elucidated on the basis of spectroscopic techniques (HRESIMS, UV, IR, NMR, and CD experiments). All of the compounds were tested for their neuroprotective activities against H2O2- and CoCl2-induced cell injuries in SH-SY5Y cells, respectively. Compounds 1-10 showed significant neuroprotective effects against H2O2-induced SH-SY5Y cell death, while compounds 1-5 and 8-10 exhibited significant neuroprotective effects against CoCl2-induced SH-SY5Y cell injury.
Subject(s)
Lignans/pharmacology , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Schisandra/chemistry , Cell Death/drug effects , Cell Survival/drug effects , Cobalt , Humans , Hydrogen Peroxide , Molecular Structure , Neuroblastoma/drug therapy , Plant Stems/chemistry , Tumor Cells, Cultured/drug effectsABSTRACT
Electroacupuncture (EA), especially high-frequency EA, has frequently been used as an alternative therapy for Parkinson disease (PD) and is reportedly effective for alleviating motor symptoms in patients and PD models. However, the molecular mechanism underlying its effectiveness is not completely understood. To implement a full-scale search for the targets of 100 Hz EA, we selected rat models treated with 6-hydroxydopamine into the unilateral MFB, which mimic end-stage PD. High-throughput microarray analysis was then used to uncover the regulated targets in the cortex and striatum after 4-week EA treatment. In the differentially regulated transcripts, the proportion of recovered expression profiles in the genes, the functional categories of targets in different profiles, and the affected pathways were analyzed. Our results suggested that the recovery of homeostasis in the transcript network and many regulated functional clusters in the cortex and striatum after EA treatment may contribute to the behavioral improvement of PD rats.
ABSTRACT
OBJECTIVE: To evaluate the therapeutic effects of acupotomy-injection with FENG Tian-you spinal manipulation (FSM) for treating cervical spondylotic radiculopathy (CSR). METHODS: Seventy-two patients with CSR were randomly divided into two groups (n = 36 respectively): treatment and control group. The patients in treatment group were treated with acupotomy-injection combined with FSM, and patients in control group were treated with traction. All the patients were followed up for 3 months after treatment and the therapeutic effects were evaluated. RESULTS: Totally there were 72 patients and 69 completed the treatment and the other 3 patients withdraw from treatment. In treatment group, 24 patients were cured, 6 patients had remarkable effects, 4 effective and 2 ineffective; as well in control group, above data were 15, 3, 10 and 8 respectively. The comprehensive effects and the cured patients in the treatment group were obviously better than those of control group (P < 0.05). The comparison of scales for assessment of symptoms and short-form McGill Pain Questionaire before and after treatment in two groups had significant differences (P < 0.001). CONCLUSION: The method of acupotomy-injection combined with FSM for treating CSR is better than conventional traction method.
Subject(s)
Acupuncture Therapy , Cervical Vertebrae , Manipulation, Spinal/methods , Radiculopathy/therapy , Spondylosis/therapy , Adult , Female , Humans , Injections , Male , Middle AgedABSTRACT
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson's disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine-herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson's disease.
Subject(s)
Electroacupuncture , Genetic Therapy , Medicine, Chinese Traditional , Parkinson Disease/therapy , Stem Cell Transplantation , Animals , Diterpenes/therapeutic use , Epoxy Compounds/therapeutic use , Glutamate Decarboxylase/genetics , Humans , Phenanthrenes/therapeutic useABSTRACT
<p><b>OBJECTIVE</b>To evaluate the therapeutic effects of acupotomy-injection with FENG Tian-you spinal manipulation (FSM) for treating cervical spondylotic radiculopathy (CSR).</p><p><b>METHODS</b>Seventy-two patients with CSR were randomly divided into two groups (n = 36 respectively): treatment and control group. The patients in treatment group were treated with acupotomy-injection combined with FSM, and patients in control group were treated with traction. All the patients were followed up for 3 months after treatment and the therapeutic effects were evaluated.</p><p><b>RESULTS</b>Totally there were 72 patients and 69 completed the treatment and the other 3 patients withdraw from treatment. In treatment group, 24 patients were cured, 6 patients had remarkable effects, 4 effective and 2 ineffective; as well in control group, above data were 15, 3, 10 and 8 respectively. The comprehensive effects and the cured patients in the treatment group were obviously better than those of control group (P < 0.05). The comparison of scales for assessment of symptoms and short-form McGill Pain Questionaire before and after treatment in two groups had significant differences (P < 0.001).</p><p><b>CONCLUSION</b>The method of acupotomy-injection combined with FSM for treating CSR is better than conventional traction method.</p>
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Acupuncture Therapy , Cervical Vertebrae , Injections , Manipulation, Spinal , Methods , Radiculopathy , Therapeutics , Spondylosis , TherapeuticsABSTRACT
OBJECTIVE: To evaluate the analgesic and therapeutic effects of electro-superficial-acupuncture (ESA) of Sanyinjiao (SP6) for treating primary dysmenorrhea (PD). METHODS: A total of 171 patients were randomly divided into ESA (n=57), superficial acupuncture (SA) (n=57) and medication (n=57) groups. For patients in SA group, bilateral SP6 were punctured superficially with special single-use needles, and for those in ESA group, after puncturing, electric stimulation (60 Hz, 2-3 V) was applied to SP6 for 30 min. Patients of medication group were ordered to take Brufen sustained-release capsules (0.3 mg, b. i. d., for 3 days), then, take it again from the 3rd day on before the onset of menstruation to the 2nd day after the onset. The cumulative score of clinical symptoms were evaluated before and after the treatment. RESULTS: Comparison among 3 groups showed that the difference values of score (pre-treatment--post-treatment) of both ESA and SA groups were significantly bigger than that of medication group (P<0.001). After the treatment from 1 min to 30 min, patients with complete relief of dysmenorrhea of ESA group were significantly more than those of SA group during the 1st menstrual cycle (P<0.05). Results of intention-to-treat (ITT) analysis showed that of the three 57 cases in ESA, SA and medication groups, the cured cases were 40, 38 and 10, the markedly effective were 9, 10 and 27, the effective were 5, 4 and 7, and the failed were 3, 5 and 13, with the total effective rates being 94.74%, 91.23% and 77.19% respectively. The effective rates of ESA and SA groups were significantly higher than that of medication group (P<0.01), and the results of per-protocol analysis (PP) were similar to those of ITT analysis. CONCLUSION: The analgesic effect of both ESA and SA at SP6 for PD patients is significantly better than that of oral administration of Brufen.
Subject(s)
Acupuncture Analgesia , Dysmenorrhea/therapy , Electroacupuncture , Acupuncture Points , Female , HumansABSTRACT
OBJECTIVE: To observe clinical therapeutic effect of superficial needling at distal and proximal acupoints on primary dysmenorrhea (PD). METHODS: One hundred and twenty cases of PD were randomly divided into a treatment group (n =60) and a control group (n = 60). The treatment group were treated with superficial needling at Sanyinjiao (SP 6) and the control group with oral administration of indometacin entric-coater tablets. RESULTS: Of the 120 cases, 116 cases completed the investigation. The total effective rate was 93. 3% in the treatment group and 75. 0% in the control group. The comprehensive therapeutic effect and the cured rate in the treatment group were significantly better than that in the control group (P<0. 001), with a more rapid effect and lasting a longer time than the control group. CONCLUSION: Clinical therapeutic effect of superficial needling at Sanyinjiao (SP 6) on primary dysmenorrhea is better than that of oral administration of indometacin entric-coater tablets.